Research
Molecular
The study proposes an approach for treating overweight and obese patients by preventing or reducing CCK1 activation.
This approach may inform future obesity treatments focusing on CCK1 regulation.
StrongSupportsmedium confidence
In this study, we propose an approach for treating overweight and obese patients, preventing or reducing CCK1 activation.
Why this rating
Based on study design from abstract.
Source
Compounds Interacting with Cholecystokinin as Potential Drugs Against Excessive Weight Gain and Obesity
José Luis Vique‐Sánchez et al. · ChemistrySelect · 2023
DOI 10.1002/slct.202300196
otherCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →